Rosetta Genomics

Rosetta Genomics

Discovering, developing, and commercializing next generation diagnostic tests for personalized medicine.

Launch date
Employees
Market cap
$29.7k
Enterprise valuation
$30k (Public information from Sep 2024)
Princeton New Jersey (HQ), Rehovot Center District (founding location)
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
N/A

$2.5m

Post IPO Equity
N/A

$2.7m

Post IPO Equity
N/A

$1.5m

Post IPO Equity
N/A

$1.8m

Post IPO Equity

$10.0m

Valuation: $10.0m

Acquisition
Total Funding-

Recent News about Rosetta Genomics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.